These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16898974)

  • 21. Strong T-transformation associated with a severe haemolytic reaction in a young infant transfused with packed red cells.
    Mullard GW; Thompson IH; Lee D; Owen WG
    Clin Lab Haematol; 1981; 3(4):357-64. PubMed ID: 7333066
    [No Abstract]   [Full Text] [Related]  

  • 22. Risks of red blood cell alloimmunization in transfusion-dependent β-thalassemia in Oman: a 25-year experience of a university tertiary care reference center and a literature review.
    Al-Riyami AZ; Al-Muqbali A; Al-Sudiri S; Murthi Panchatcharam S; Zacharia M; Al-Mahrooqi S; Al-Hosni S; Al-Marhoobi A; Daar S
    Transfusion; 2018 Apr; 58(4):871-878. PubMed ID: 29399805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody screening in multitransfused patients: a prerequisite before each transfusion.
    Lamba DS; Mittal K; Sood T; Bedi RK; Kaur P; Kaur G
    Transfus Apher Sci; 2014 Oct; 51(2):132-3. PubMed ID: 25294114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A confusion in antibody identification: anti-D production after anti-hrB.
    Lomas-Francis C; Yomtovian R; McGrath C; Walker PS; Reid ME
    Immunohematology; 2007; 23(4):158-60. PubMed ID: 18284306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transfusion therapy and alloimmunization in Thalassemia Intermedia: a 10 year experience at a tertiary care university hospital.
    Al-Riyami AZ; Al-Mahrooqi S; Al-Hinai S; Al-Hosni S; Al-Madhani A; Daar S
    Transfus Apher Sci; 2014 Aug; 51(1):42-6. PubMed ID: 24816438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The basics of transfusion. 1. General transfusion methods and treatment with erythrocyte concentrates].
    Michaelis C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Mar; 33(3):177-98. PubMed ID: 9581232
    [No Abstract]   [Full Text] [Related]  

  • 27. Red cell transfusions and blood groups.
    Vox Sang; 2004 Oct; 87(3):210-22. PubMed ID: 15569091
    [No Abstract]   [Full Text] [Related]  

  • 28. Red cell alloimmunisation in paroxysmal nocturnal hemoglobinuria.
    Basu S; Tahlan A; Kaur G; Kaur R; Garg S; Cruz SD
    J Assoc Physicians India; 2011 Feb; 59():128. PubMed ID: 21751657
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunologic risk analysis of blood transfusion: 1991-1998].
    Rouger P; Le Pennec PY; Noizat-Pirenne F
    Transfus Clin Biol; 2000 Feb; 7(1):9-14. PubMed ID: 10730341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study of platelet alloantibody in multiply-transfused haematology patients.
    Linn YC; Prakash P; Ong YW
    Ann Acad Med Singap; 1995 Mar; 24(2):305-11. PubMed ID: 7653976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The future of red blood cell alloimmunization risk reduction.
    Karafin MS; Denomme GA; Bryant BJ
    Transfusion; 2015 Jan; 55(1):220-1. PubMed ID: 25582238
    [No Abstract]   [Full Text] [Related]  

  • 32. Comment on "Applying molecular immunohaematology to regularly transfused thalassaemic patients in Thailand".
    Manfroi S; Pagliaro P
    Blood Transfus; 2015 Jan; 13(1):164-5. PubMed ID: 25369596
    [No Abstract]   [Full Text] [Related]  

  • 33. A case report on anti-Mia antibody in a multi-transfused patient from India.
    Agrawal S; Chowdhry M
    Transfus Apher Sci; 2019 Oct; 58(5):625-627. PubMed ID: 31515172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characteristics of anti-Coa antibodies of the Colton blood group system and their significance in hemotherapy].
    Kuśnierz G; Bragiel I; Nowakowska E; Cwirko Z
    Acta Haematol Pol; 1983; 14(2):117-24. PubMed ID: 6673468
    [No Abstract]   [Full Text] [Related]  

  • 35. [Severe bleeding in a patient with anti-c alloantibodies and a rare Rhesus phenotype treated with compatible erythrocyte concentrate from the blood bank of the Council of Europe].
    Sonke GS; Overbeeke MA; de Graaff WE; Elisen MG
    Ned Tijdschr Geneeskd; 2005 Nov; 149(47):2628-32. PubMed ID: 16355576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-D alloimmunization by weak D type 1 red blood cells with a very low antigen density.
    Mota M; Fonseca NL; Rodrigues A; Kutner JM; Castilho L
    Vox Sang; 2005 Feb; 88(2):130-5. PubMed ID: 15720611
    [No Abstract]   [Full Text] [Related]  

  • 37. Red cell immunization in multiply transfused Malay thalassemic patients.
    Noor Haslina MN; Ariffin N; Illuni Hayati I; Rosline H
    Southeast Asian J Trop Med Public Health; 2006 Sep; 37(5):1015-20. PubMed ID: 17333748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective evaluation of a transfusion policy of D+ red blood cells into D- patients.
    Gonzalez-Porras JR; Graciani IF; Perez-Simon JA; Martin-Sanchez J; Encinas C; Conde MP; Nieto MJ; Corral M
    Transfusion; 2008 Jul; 48(7):1318-24. PubMed ID: 18422846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review: transfusing incompatible RBCs--clinical aspects.
    Meny G
    Immunohematology; 2004; 20(3):161-6. PubMed ID: 15373647
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunological consequences of blood transfusions.
    Claas FH; Lagaay EL; van Rood JJ
    Schweiz Med Wochenschr Suppl; 1991; 43():70-2. PubMed ID: 1688196
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.